46 found that TCDD could alter AR activity differentially in androgen sensitive or insensitive prostate cancer cells. Furthermore, AR‐Q polymorphisms interact with AhR to influence cancers. For example, Björk et al. 27 found that TCDD selectively affects prostate cancer cell AR action, which might involve refractory cancer progression. The gene discussed is AHR; the disease is prostate carcinoma.